Ligands of the Molecule Fit (Agt-121) and their Pharmaceutical Use
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
May 8, 2008
app pub date -
Mar 16, 2005
filing date -
Mar 16, 2004
priority date (Note) -
Abandoned
status (Latency Note)
Importance
Abstract
Identification of molecules which modulate inter alia obesity, anorexia, weight maintenance, inflammation and/or metabolic energy levels in a subject are described which particularly relate to a protein molecule called 'FIT', previously known as 'AGT-121'. Ligands of 'FIT' as well as antagonists of 'FIT'-ligand interaction are proposed to modulate inter alia obesity, anorexia, weight maintenance, inflammation and/or metabolic energy levels in a subject. Methods of treatment and prophylaxis and pharmaceutical compositions useful in modulating inter alia obesity, anorexia, weight maintenance, inflammation and/or metabolic energy levels are also provided.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully